To confirm whether the previously documented peripheral increase in KYN promoted KYNA production under our conditions, we measured serum KYN and KYNA levels, brain KYNA levels and KATII activity, and the GSH/GSSG ratio 24 h after the last administration of CIS. This evidence concerns the gene AADAT and in situ carcinoma.